Aug 8 (Reuters) - Benitec Biopharma Ltd BLT.AX
* Benitec Biopharma says its BB-301, represents clinical candidate that it intends to advance into human clinical trials in the second half of 2018
* Benitec Biopharma says working with regulators to advance BB-301 into the clinic as quickly as possible